Table 1.
Effect of silibinin on CEES- or NM-induced injury end points in skin epidermal cells, skin fibroblasts, or SKH-1 hairless mice
Injury end point | Model and vesicant | Effect of silibinin |
---|---|---|
Cell viability | Skin epidermal cells and fibroblast models with CEES | Decreases the CEES-induced Increase42 |
Apoptotic cell death | Skin epidermal cells and fibroblast models with CEES SKH-1 hairless mouse skin injury model with CEES and NM |
Decreases the CEES- and NM- induced increase42,70 |
Cellular and mitochondrial oxidative stress | Skin epidermal cells and fibroblast models with CEES | Decreases the CEES-induced increase42 |
Skin epidermal thickness, denuding, or other changes | SKH-1 hairless mouse skin injury model with CEES and NM | Decreases the CEES- and NM- induced increase42,70 |
Microvesication | SKH-1 hairless mouse skin injury model with NM | Decrease in NM-induced increase70 |
Myeloperoxidase activity | SKH-1 hairless mouse skin injury model with CEES and NM | Decreases the CEES- and NM- induced increase42,70 |
DNA damage (H2A.X or p53 phosphorylation) | Skin epidermal cells and fibroblast models with CEES SKH-1 hairless mouse skin injury model with CEES and NM |
Decreases the CEES- and NM- induced increase42,70 |
Inflammatory and proteolytic mediators (COX-2, iNOS, MMP9) | SKH-1 hairless mouse skin injury model with CEES and NM | Decreases the CEES- and NM- induced increase42,70 |
Transcription factors AP-1 and NF-κB | SKH-1 hairless mouse skin injury model with CEES | Decreases the CEES-induced increase42 |
Lipid peroxidation, protein oxidation, and oxidative DNA damage | SKH-1 hairless mouse skin injury model with CEES and NM | Decreases the CEES- and NM- induced increase42,70 |